SHPA Standards of Practice for Clinical Pharmacy

Abstract

Data collection and reporting, audit review of quality and safetyDecision to prescribe medicine Record medicine order (prescribe) Review of medicine order Issue of medicine Provision of medicine information Distribution and storage of medicine Administration of medicine (re-assessment, preparation, administration and recording) Monitor for response Transfer of verified information Medicines procurement and materials management Decision on appropriate treatment Consumer Effective communication of accurate, complete and comprehensive information Figure 1. Overview of the medicines management pathway cycle (reproduced from J Pharm Pract Res 2004; 34: 294.

Evaluation of a Clinical Pharmacist Intervention on Clinical and Drug-Related Problems Among Coronary Heart Disease Inpatients: A pre-experimental prospective study at a general hospital in Indonesia

“…The severity of identified DRPs was classified as major, moderate or minor. 20 Major DRPs were defined as those requiring intervention to prevent major or irreversible detrimental effects or due to lack of appropriate therapy in circumstances where evidence-based options were available. Moderate DRPs included DRPs whereby interventions would result in moderate benefit for the patient, while minor DRPs were defined as those requiring only minor adjustments, such as modifications to dosage timings.…”

“…Moderate DRPs included DRPs whereby interventions would result in moderate benefit for the patient, while minor DRPs were defined as those requiring only minor adjustments, such as modifications to dosage timings. 20 Harmful, unpleasant and unintended responses to drugs at normal doses were considered to constitute ADRs. 17 The probable consequences of a lack of intervention were categorised as insignificant, minor, moderate, major or catastrophic.…”

“…17 The probable consequences of a lack of intervention were categorised as insignificant, minor, moderate, major or catastrophic. 20 For example, insignificant consequences referred to circumstances where no harm or injury to the patient and a low financial loss would result as a lack of intervention. Minor consequences included minor injuries, minor treatment, no prolonged length of stay (LOS) or re-admission to the hospital and the potential for minor financial loss, while moderate consequences included major temporary injuries, prolonged LOS or re-admission to the hospital, a cancellation or delay in planned treatments/ procedures and the potential for financial loss.…”

“…Finally, catastrophic consequences of a lack of intervention included the death of the patient, the potential for large financial losses and/or threat to the patient's goodwill or reputation. 20 Data were analysed using the Statistical Package for the Social Sciences (SPSS), Version 23.0 (IBM Corp., Armonk, New York, USA). A Wilcoxon signedrank test was used to assess the differences between pre-and post-intervention DRPs and clinical problems.…”

The Position of Clinical Pharmacists in Delivering Advanced Pharmacy Practice Education and Services

“…This may include participation in the management of individual patients; application of the best available evidence in daily clinical practice; and contribution of clinical knowledge and skills to the healthcare team. 8 The primary focus of community pharmacy as component of pharmacy practice is to provide professional care to patients, supported by safe and effective medication management and medication information, comprehensive warfarin counselling, smoking cessation counselling, MUR-medicine use reviews, free emergency contraception counselling and dispensing, flu vaccination campaigns, waste management and DUMP (Dispose Unwanted Medicines Programme) and medication counselling for patients initiated on medicines for mild to moderate depression in which all require an in-depth clinical pharmacy knowledge. and maintenance of required records.…”